Translation of "Sa 02 " (French → English) :

Definition: A disorder characterized by impairment of memory, learning difficulties, and reduced ability to concentrate on a task for more than brief periods. There is often a marked feeling of mental fatigue when mental tasks are attempted, and new learning is found to be subjectively difficult even when objectively successful. None of these symptoms is so severe that a diagnosis of either dementia (F00-F03) or delirium (F05.-) can be made. This diagnosis should be made only in association with a specified physical disorder, and should not be made in the presence of any of the mental or behavioural disorders classified to F10-F99. The d ...[+++]isorder may precede, accompany, or follow a wide variety of infections and physical disorders, both cerebral and systemic, but direct evidence of cerebral involvement is not necessarily present. It can be differentiated from postencephalitic syndrome (F07.1) and postconcussional syndrome (F07.2) by its different etiology, more restricted range of generally milder symptoms, and usually shorter duration.

Definition: Personality disorder characterized by excessive sensitivity to setbacks, unforgiveness of insults; suspiciousness and a tendency to distort experience by misconstruing the neutral or friendly actions of others as hostile or contemptuous; recurrent suspicions, without justification, regarding the sexual fidelity of the spouse or sexual partner; and a combative and tenacious sense of personal rights. There may be excessive self-importance, and there is often excessive self-reference. | Personality (disorder):expansive paranoid | fanatic | querulant | paranoid | sensitive paranoid

Quest airlock [ airlock Quest | joint airlock | Space Station airlock | US airlock | Quest ]

Her Majesty the Queen in right of Canada [ Her Majesty in right of Canada ]

pitch one's tent

bike box

change slot

bike box | bicycle box | cycle box

Definition: A chronic stage in the development of a schizophrenic illness in which there has been a clear progression from an early stage to a later stage characterized by long- term, though not necessarily irreversible, negative symptoms, e.g. psychomotor slowing; underactivity; blunting of affect; passivity and lack of initiative; poverty of quantity or content of speech; poor nonverbal communication by facial expression, eye contact, voice modulation and posture; poor self-care and social performance. | Chronic undifferentiated schizophrenia Restzustand (schizophrenic) Schizophrenic residual state

Lives with relatives

Box reference I. 19: Use the appropriate Harmonised System (HS) code under the following headings: 04.01; 04.02; 04.03; 04.04; 04.05; 04.06; 15.17; 17.02; 21.05; 22.02; 28.35; 35.01; 35.02 or 35.04’.

Box reference I. 19: use the appropriate Harmonised System (HS) code under the following headings: 04.01; 04.02; 04.03; 04.04; 04.05; 04.06; 15.17; 17.02; 19.01; 21.05; 21.06; 22.02; 28.35; 35.01; 35.02 or 35.04’.

02.040201 – Leadership in space 02.040203 – Increasing innovation in small and medium-sized enterprises (SMEs) 02.040301 – Achieving a resource-efficient and climate change resilient economy and a sustainable supply of raw materials 02.040302 – Fostering secure European societies || 11 1.8 3.7 7.5 || 29.9 2.1 7.0 25 || 27.9 6.1 7 25 || 11.6 6.5 17.5 10.4 || || || 80.4 16.5 35.2 67.9

The European Food Safety Authority has completed the assessment of 23 substances which are currently listed as flavouring substances under evaluation. Those flavouring substances were assessed by the EFSA in the following flavouring group evaluations: evaluation FGE.06rev4 (substances FL Nos 02.229, 05.137, 09.562 and 09.854), evaluation FGE.07rev4 (substances FL Nos 02.145, 02.194, 02.211, 07.198 and 07.204), evaluation FGE.08rev5 (substance FL No 15.134), evaluation FGE.09rev4 (substances FL Nos 07.202 and 07.255), evaluation FGE.12rev3 (substance FL No 05.182), evaluation FGE.20rev4 (substances FL Nos 05.026, 05.028, 05.029 and 09.858), evaluation in FGE.23rev4 (substance FL No 13.170), evaluation in FGE.63rev1 (substances FL Nos 02.252, ...[+++] 07.190 and 09.936), evaluation FGE.94rev1 (substance FL No 16.095) and evaluation FGE.304 (substance FL No 16.123).